Indole and Indazole Compounds for AMPK Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetes, obesity, dyslipidemia, and renal diseases, such as diabetic nephropathy and polycystic kidney disease, lack effective activators of 5' adenosine monophosphate-activated protein kinase (AMPK), which are crucial for metabolic regulation and tissue health.
Innovation Solution
Development of indole and indazole compounds that activate AMPK, specifically those of Formula (I) with defined structural components, and their use in pharmaceutical compositions to treat or prevent metabolic disorders and renal diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for diabetes and metabolic disorders are used, then current standard therapies are available, but effective AMPK activation is lacking
Solution Approach 1:
The patent modifies molecular parameters by developing specific indole and indazole compound structures (Formula I) with varying substituents (R1-R10) to optimize AMPK activation. This involves changing chemical parameters such as molecular weight, lipophilicity, and structural configuration to achieve effective AMPK activation while maintaining drug-like properties and metabolic stability.
2Reliability
If new AMPK-activating compounds are developed, then metabolic regulation is improved, but drug development complexity increases
Solution Approach 1:
The patent segments the complex AMPK activator development into manageable components by defining a core indole/indazole structure (Formula I) with specific functional groups. The molecule is divided into identifiable segments (R1-R10 substituents) that can be independently optimized, allowing systematic structure-activity relationship studies while maintaining overall therapeutic efficacy.
Solution Approach 2:
The patent systematically varies molecular parameters within the indole/indazole framework to optimize the balance between AMPK activation potency and structural complexity. By adjusting substituent parameters (R1-R10) within defined constraints, the invention achieves effective metabolic regulation without excessive molecular complexity.
3Reliability
If AMPK activation is enhanced for better metabolic control, then glucose and lipid metabolism improve, but potential off-target effects may increase
Solution Approach 1:
The patent applies local quality by designing the indole/indazole compound to interact specifically with the AMPK active site through carefully positioned functional groups. The molecular structure is optimized to create specific local interactions (hydrogen bonding, hydrophobic contacts, electrostatic interactions) with AMPK, ensuring selective activation while minimizing off-target effects on other kinases or cellular targets.
Data Source
Figure 1A~1D
AI summary
The present invention relates to indole and indazole compounds of Formula (I) that activate 5' adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.